tradingkey.logo
tradingkey.logo
Search

Indaptus Therapeutics Inc

INDP
Add to Watchlist
1.290USD
-0.150-10.42%
Close 07-31 16:00ETQuotes delayed by 15 min
146.08MMarket Cap
LossP/E TTM

INDP Financials

See Indaptus Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Indaptus Therapeutics Inc Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
-0.23/-1.87
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-21.58
52.00%
Analyst Rating
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
97.42%-0.23
57.36%-4.51
66.98%-2.98
30.88%-9.09
28.72%-9.00
20.64%-10.59
30.88%-9.04
-21.67%-13.16
10.94%-12.63
-7.82%-13.34
---13.07
---10.82
---14.18
---12.37
----
----
----
----
----
----
Net Profit
43.94%-2.54M
-96.38%-8.11M
3.06%-2.98M
-30.23%-5.23M
-19.07%-4.53M
-3.20%-4.13M
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-9.49%-4.00M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
9.93%-3.22M
9.97%-3.37M
82.51%-515.48K
Debt to assets ratio
----
----
----
--95.08%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
52.77%-2.16M
-95.51%-8.16M
15.71%-2.65M
-8.47%-4.46M
-15.96%-4.57M
0.19%-4.17M
26.04%-3.14M
-17.56%-4.11M
11.49%-3.94M
-2.27%-4.18M
-19.59%-4.25M
9.67%-3.50M
-30.95%-4.46M
-26.99%-4.09M
-5.48%-3.55M
-631.92%-3.87M
-454.11%-3.40M
9.18%-3.22M
7.50%-3.37M
81.80%-528.64K
Net Profit
43.94%-2.54M
-96.38%-8.11M
3.06%-2.98M
-30.23%-5.23M
-19.07%-4.53M
-3.20%-4.13M
21.76%-3.07M
-23.73%-4.02M
10.50%-3.81M
-9.49%-4.00M
-13.16%-3.92M
15.39%-3.25M
-26.39%-4.25M
-13.66%-3.66M
-2.95%-3.47M
-644.07%-3.84M
-449.48%-3.37M
9.93%-3.22M
9.97%-3.37M
82.51%-515.48K
Current assets
-56.04%2.18M
40.67%9.31M
-15.60%6.44M
-14.36%6.41M
-51.80%4.96M
-52.71%6.62M
-54.70%7.63M
-62.32%7.49M
-53.54%10.29M
-48.63%14.00M
-43.08%16.84M
-40.27%19.87M
-40.00%22.15M
-32.54%27.24M
-32.52%29.59M
77.06%33.27M
203.64%36.92M
169.82%40.39M
147.98%43.85M
24.40%18.79M
Total current liabilities
-64.28%933.00K
81.46%6.16M
0.08%2.23M
341.51%8.51M
69.90%2.61M
22.34%3.39M
-5.61%2.23M
-8.32%1.93M
-15.65%1.54M
-19.20%2.77M
-17.90%2.37M
-41.97%2.10M
-50.47%1.82M
-25.43%3.43M
-50.16%2.88M
-33.38%3.62M
-29.28%3.68M
-13.68%4.60M
27.04%5.78M
24.23%5.44M
Total assets
-59.70%2.18M
26.86%9.31M
-16.99%6.84M
-15.79%6.84M
-50.57%5.41M
-50.83%7.34M
-53.69%8.24M
-61.04%8.12M
-52.70%10.95M
-46.82%14.92M
-41.57%17.79M
-38.80%20.84M
-37.59%23.14M
-30.84%28.06M
-30.57%30.45M
69.52%34.06M
112.77%37.09M
94.18%40.58M
82.47%43.86M
-7.76%20.09M
Total liabilities
-64.28%933.00K
81.46%6.16M
-0.10%2.23M
335.29%8.51M
64.48%2.61M
19.19%3.39M
-9.10%2.24M
-11.88%1.96M
-18.95%1.59M
-17.07%2.85M
-14.74%2.46M
-39.23%2.22M
-47.48%1.96M
-26.59%3.43M
-50.08%2.89M
-40.68%3.65M
-38.71%3.73M
-26.50%4.68M
-3.00%5.78M
9.83%6.16M
Total equity
-55.43%1.25M
-20.11%3.15M
-23.28%4.61M
-127.14%-1.67M
-70.09%2.80M
-67.33%3.94M
-60.85%6.00M
-66.89%6.17M
-55.82%9.36M
-50.97%12.08M
-44.38%15.33M
-38.75%18.63M
-36.49%21.19M
-31.39%24.63M
-27.61%27.57M
118.19%30.41M
194.04%33.36M
147.02%35.90M
110.65%38.08M
-13.86%13.94M
Net operating income
-38.89%-7.01M
6.04%-3.19M
-2.16%-2.57M
-62.16%-4.02M
-28.21%-5.05M
-30.51%-3.40M
32.71%-2.51M
-17.62%-2.48M
20.67%-3.94M
-17.69%-2.60M
18.84%-3.73M
33.08%-2.11M
-59.16%-4.96M
37.54%-2.21M
-1200.53%-4.60M
-143.15%-3.15M
-277.64%-3.12M
-33.57%-3.54M
82.69%-353.82K
22.47%-1.29M
Net investment
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
338.17%7.00M
150.60%8.00M
176.50%2.14M
1033.64%5.12M
-76159.86%-2.94M
-718506.23%-15.81M
---2.80M
7626.67%451.60K
70.35%-3.85K
---2.20K
Net financing
----
225.92%5.87M
-13.76%2.24M
16411.32%6.28M
897.13%3.15M
--1.80M
--2.59M
--38.06K
--316.05K
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
411.35%363.06K
599.95%37.12M
-60.48%1.77M

FAQs

What are the current assets of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its current assets were 9.31M, with a year-on-year change of 40.67.

What are the total assets of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its total assets of Indaptus Therapeutics Inc were 9.31M, with a year-on-year change of 26.86.

What are the total liabilities of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its total liabilities of Indaptus Therapeutics Inc were 6.16M, with a year-on-year change of 81.46.

What is the total equity of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its total equity of Indaptus Therapeutics Inc was 3.15M, with a year-on-year change of -20.11.

What is the net operating income of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its net operating income of Indaptus Therapeutics Inc was -19.83M, with a year-on-year change of -29.08.

What is the net financing of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its net financing of Indaptus Therapeutics Inc was 17.54M, with a year-on-year change of 269.51.

What is the Earnings Per Share (EPS) of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -21.58, with a year-on-year change of 52.00.

What is the net income of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its net income was -20.85M, with a year-on-year change of -38.79.

What is the Return on Equity (ROE) of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -588.41, with a year-on-year change of -213.78.

What is the Return on Assets (ROA) of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -250.45, with a year-on-year change of -85.59.

What is the operating profit of Indaptus Therapeutics Inc?

According to Indaptus Therapeutics Inc's FY2025 earnings report, its operating profit was -19.83M, with a year-on-year change of -29.08.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.